99% pure high quality raw material bromfenac sodium CAS 120638-55-3 with Best Price
120638-55-3
Pharmaceutical Grade
99%
shenzhen
1kg/bag;25kg/Cardboard Drum
2025-03-28
Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceDuract was launched in the US as a potent, orally-active, long lasting peripheral analgesic with antiinflammatory properties. It is structurally similar to ketoprofen and diclofenac and can be prepared in three steps from 2-amino-4’-bromophenone using Gassman’s oxindole synthesis. Duract’s biological effects are a result of its ability to reduce prostaglandin production through inhibition of cyclooxygenase. As a 4-bromo derivative of Amfenac, this modification increased the duration of analgesic activity and antiinflammatory potency. It was also free of any CNS, cardiovascular or autonomic effects. In comparison, 5 mg of Duract was equipotent to 650 mg of ASA and 25 mg was slightly more potent than 400 mg of Ibuprofen.
Yellow Solid
ChEBI: The sesquihydrate of the sodium salt of bromfenac. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction.Basic Info-
Product Name:
Bromfenac monosodium salt sesquihydrate
Other Name:Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate;Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt, hydrate (2:3);Bromfenac ophthalmic;Bromfenac ophthalmic solution;Duract;Sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate;Unii-8ecv571Y37;Bromfenac monosodium salt sesquihydrate
CAS No.:120638-55-3
Molecular Formula:C15H11BrNNaO3
InChIKeys:ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
Molecular Weight:356.15
EC Number:695-342-6
Color/Form:Light yellow to yellow
Categories:
Characteristics-
Melting Point:
268-270°C (dec.)
Critical Temperature & Pressure:Refrigerator
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10
-
Location:
XINYUAN DADUHUI PHASE 1, NO.258 TAOYUAN NORTH ROAD, LIANHU DISTRICT, XI 'AN , SHAANXI CHINA
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product